| Overview |
| bsm-90211r-50µL |
| PFKFB3 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human PFKFB3 |
| 300-520/520 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 5209 |
| Q16875 |
| PFKFB3; 6-Phosphofructo-2-Kinase/Fructose-26-Biphosphatase 3; 6-Phosphofructo-2-Kinase/Fructose-26-Bisphosphatase 3; 6PF-2-K/Fru-26-P2ase Brain/Placenta-Type Isozyme 3; Renal Carcinoma Antigen NY-REN-56; 6PF-2-K/Fru-26-P2ase 3; PFK/FBPase 3; IPFK-2; Inducible 6-Phosphofructo-2-Kinase/Fructose-26-Bisphosphatase; Fructose-6-Phosphate2-Kinase/Fructose-2 6-Bisphosphatase; 6-Phosphofructo-2-Kinase/ Fructose-26-Bisphosphatase; IPFK2; PFK2 |
| Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz